Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100QKFA
Period2022-06-01 → 2023-02-28
Filed2023-04-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥38.6bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥1.0bn2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥967m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥322m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥326m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥22.9bnat 2023-02-28Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.8bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2023-02-28Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.6bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.62021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.682021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.162021-06-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.4%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2022-02-28¥22m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥235m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2022-02-28−¥151m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2022-02-28¥71m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2022-02-28¥1.2bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2022-02-28¥48m
—segment totalrevenue2021-06-01 → 2022-02-28¥38.0bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥38.0bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Liabilities and net assetsPrior1YearInstant23746000000JPY
Liabilities and net assetsCurrentQuarterInstant22935000000JPY
Net salesPrior1YTDDuration38579000000JPY
Net salesCurrentYTDDuration38730000000JPY
Cost of salesPrior1YTDDuration32512000000JPY
Cost of salesCurrentYTDDuration32717000000JPY
Gross profitPrior1YTDDuration6066000000JPY
Gross profitCurrentYTDDuration6013000000JPY
Selling general and administrative expensesPrior1YTDDuration5065000000JPY
Selling general and administrative expensesCurrentYTDDuration5116000000JPY
Operating incomePrior1YTDDuration1000000000JPY
Operating incomeCurrentYTDDuration896000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration1000000JPY
Dividends income noiPrior1YTDDuration1000000JPY
Dividends income noiCurrentYTDDuration1000000JPY
Commission fee noiPrior1YTDDuration10000000JPY
Commission fee noiCurrentYTDDuration20000000JPY
Rent income noiPrior1YTDDuration12000000JPY
Rent income noiCurrentYTDDuration12000000JPY
Other noiPrior1YTDDuration86000000JPY
Other noiCurrentYTDDuration21000000JPY
Non operating incomePrior1YTDDuration112000000JPY
Non operating incomeCurrentYTDDuration57000000JPY
Interest expenses noePrior1YTDDuration49000000JPY
Interest expenses noeCurrentYTDDuration40000000JPY
Rent cost noePrior1YTDDuration7000000JPY
Rent cost noeCurrentYTDDuration8000000JPY
Other noePrior1YTDDuration40000000JPY
Other noeCurrentYTDDuration13000000JPY
Non operating expensesPrior1YTDDuration98000000JPY
Non operating expensesCurrentYTDDuration62000000JPY
Ordinary incomePrior1YTDDuration1014000000JPY
Ordinary incomeCurrentYTDDuration890000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration2000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration1000000JPY
Reversal of provision for loss on store closing eiPrior1YTDDuration21000000JPY
Reversal of provision for loss on store closing eiCurrentYTDDuration16000000JPY
Subsidy eiPrior1YTDDuration－JPY
Subsidy eiCurrentYTDDuration61000000JPY
Extraordinary incomePrior1YTDDuration23000000JPY
Extraordinary incomeCurrentYTDDuration80000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration5000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration18000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration31000000JPY
Impairment loss elPrior1YTDDuration52000000JPY
Impairment loss elCurrentYTDDuration46000000JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration－JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration61000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass